Fact CheckerSign in

NCT03527342Enrolling by invitation

Sahlgrenska Cardiomyopathy Project

Sahlgrenska University Hospital Cardiomyopathy Project: Mapping and Diagnosis of Cardiomyopathies to Enable Early and Specific Treatment

Source: ClinicalTrials.gov · Last updated 6 Nov 2018 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal. Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP) including in depth clinical and molecular phenotyping to enable earlier and specific treatment. The project will serve as: 1. resource for diagnostic and therapeutic trials 2. common biomaterial bank 3. resource for detailed molecular analyses on patients' biomaterials and patient specific symptoms and examination results

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
3000 (estimated)
First submitted
23 Apr 2018
Start date
1 Jun 2018
Primary completion date
Jan 2028
Lead sponsor
Göteborg University
NCT number
NCT03527342

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 1 Jun 2018 to the primary completion date, Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patient with other preexisting cardiac diseases such as significant valvular, ischemic or pericardial disease before they receive a cardiomyopathy diagnose

Age

  • patients \< 18 years

Who the study is looking for

  • Patients with primary cardiomyopathies including hereditary and inflammatory dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, left ventricular non-compaction cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, giant cell myocarditis, sarcoidosis and amyloidosis engaging the heart

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Göteborg University, Sahlgrenska Universitetssjukhuset
Coordinator of this site? Confirm its status
GothenburgSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.